Does professional advice influence aspirin use to prevent heart disease in an HMO population?

Effective clinical practice : ECP Pub Date : 1998-08-01
P J O'Connor, N P Pronk, A W Tan, W A Rush, R J Gray
{"title":"Does professional advice influence aspirin use to prevent heart disease in an HMO population?","authors":"P J O'Connor,&nbsp;N P Pronk,&nbsp;A W Tan,&nbsp;W A Rush,&nbsp;R J Gray","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Aspirin use seems to reduce coronary artery disease events in some groups of patients. Factors associated with use of aspirin to prevent heart disease in an HMO population were examined.</p><p><strong>Design: </strong>A population-based survey.</p><p><strong>Setting: </strong>A large HMO in the midwestern United States.</p><p><strong>Participants: </strong>8000 health plan members 40 years of age and older.</p><p><strong>Main outcome measures: </strong>The survey assessed use of aspirin, professional advice to use aspirin, and coronary heart disease risk factors and status. The sample was stratified by whether members had none, one, or more than one of the following chronic conditions: diabetes, hypertension, lipid disorder, or heart disease. The mailed survey had a corrected response rate of 82.4%.</p><p><strong>Results: </strong>Overall, 38% of respondents reported using aspirin at least three times a week to prevent heart disease. Aspirin use did not vary in owned versus contracted clinics. Aspirin use was 71.3% in patients with and 27.7% in patients without diagnosed coronary heart disease (P < 0.001). In logistic regression models, professional advice to take aspirin was strongly associated with self-reported use of aspirin (odds ratio, 13.86) (P < 0.001) after adjustment for age, sex, level of education, and chronic disease status.</p><p><strong>Conclusions: </strong>Aspirin is widely used by HMO members with coronary artery disease to prevent subsequent coronary artery disease events. Professional advice to use aspirin seems to be strongly related to aspirin use.</p>","PeriodicalId":79873,"journal":{"name":"Effective clinical practice : ECP","volume":"1 1","pages":"26-32"},"PeriodicalIF":0.0000,"publicationDate":"1998-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Effective clinical practice : ECP","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Aspirin use seems to reduce coronary artery disease events in some groups of patients. Factors associated with use of aspirin to prevent heart disease in an HMO population were examined.

Design: A population-based survey.

Setting: A large HMO in the midwestern United States.

Participants: 8000 health plan members 40 years of age and older.

Main outcome measures: The survey assessed use of aspirin, professional advice to use aspirin, and coronary heart disease risk factors and status. The sample was stratified by whether members had none, one, or more than one of the following chronic conditions: diabetes, hypertension, lipid disorder, or heart disease. The mailed survey had a corrected response rate of 82.4%.

Results: Overall, 38% of respondents reported using aspirin at least three times a week to prevent heart disease. Aspirin use did not vary in owned versus contracted clinics. Aspirin use was 71.3% in patients with and 27.7% in patients without diagnosed coronary heart disease (P < 0.001). In logistic regression models, professional advice to take aspirin was strongly associated with self-reported use of aspirin (odds ratio, 13.86) (P < 0.001) after adjustment for age, sex, level of education, and chronic disease status.

Conclusions: Aspirin is widely used by HMO members with coronary artery disease to prevent subsequent coronary artery disease events. Professional advice to use aspirin seems to be strongly related to aspirin use.

在HMO人群中,专业建议是否会影响阿司匹林预防心脏病的使用?
目的:阿司匹林的使用似乎可以减少某些患者的冠状动脉疾病事件。研究了在HMO人群中使用阿司匹林预防心脏病的相关因素。设计:基于人群的调查。地点:美国中西部的一家大型卫生组织。参与者:8000名40岁及以上的健康计划成员。主要结局指标:调查评估了阿司匹林的使用情况、阿司匹林的专业建议以及冠心病的危险因素和状况。根据成员是否没有、一种或一种以上的下列慢性疾病对样本进行分层:糖尿病、高血压、脂质紊乱或心脏病。邮寄调查的修正回复率为82.4%。结果:总体而言,38%的受访者表示每周至少使用三次阿司匹林来预防心脏病。阿司匹林的使用在自有诊所和签约诊所没有差异。冠心病患者阿司匹林使用率为71.3%,未确诊冠心病患者为27.7% (P < 0.001)。在logistic回归模型中,经年龄、性别、教育水平和慢性疾病状态调整后,服用阿司匹林的专业建议与自我报告的阿司匹林使用密切相关(优势比,13.86)(P < 0.001)。结论:HMO会员冠心病患者广泛使用阿司匹林预防继发冠心病事件。服用阿司匹林的专业建议似乎与阿司匹林的使用密切相关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书